On September 30, 2010, our clinical team submitted the second protocol amendment for our recently initiated U.S. study of MDMA-assisted psychotherapy for veterans with PTSD to the FDA for review.
On September 30, 2010, our clinical team submitted the second protocol amendment for our recently initiated U.S. study of MDMA-assisted psychotherapy for veterans with PTSD to the FDA for review.